Clinical Trial Update: A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating JNJ-40411813 in combination with levetiracetam or brivaracetam for focal onset seizures in epilepsy; the trial has completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Focal Onset Seizures

Drugs mentioned

• BRIVARACETAM (brivaracetam)
• JNJ-40411813
• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Focal Onset Seizures | Phase 2 | Status: COMPLETED | Results posted: 2025-07-03